Delivery Order SPE2DB20D1100-SPE2DB24FZ90B
- Not listed
- This federal contract award, valued at $1,112.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of MICARDIS HCT 80-12.5 MG TABLET UD 30S, a cardiovascular medication. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary...
- This federal contract award, valued at $2,761.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a pharmaceutical product, with a completion date of January 14, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00 through November 2026. The IDC serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of MICARDIS HCT 80-12.5 MG TABLET UD 30S, a pharmaceutical product. The award, valued at $1,700.06, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,243.22 firm-fixed-price delivery order is for the supply of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of...
- This federal contract award, valued at $1,437.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of MICARDIS HCT 80-25 MG TABLET UD 30S, a pharmaceutical product, to support military healthcare programs. This is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,093.50 firm fixed price delivery order is for MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which runs through November 2026. The IDC enables the DLA to efficiently procure a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,007.78, is for the delivery of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication. The contract is a Firm Fixed Price Delivery Order with a completion date of February 15, 2024. This award is not associated with a set-aside program and was made through full and open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $3,950.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company owned by the parent company Cencora, Inc. The contract is a Delivery Order for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication. This order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,237.30, is for the delivery of Micardis HCT 40-12.5 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $3,423.13 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563617394 MICARDIS HCT 80-25 MG TABLET UD 30S, with a period of performance through February 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999 and running through November...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FZ90BDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,637.40 firm-fixed-price delivery order is for the pharmaceutical product MICARDIS HCT 40-12.5 MG TABLET UD 30S. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating full and open competition. This delivery order demonstrates Amerisourcebergen Drug Corp's role as a critical supplier of essential medications to the U.S. Department of Defense and its healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/25/24 |